A Study Of Comprehensive Genicular Nerve Radiofrequency Ablation For Refractory Knee Pain Using A Dual-Tined Electrode

Overview

About this study

The purpose of this study is to evaluate the effectiveness of a comprehensive genicular nerve RFA targeting technique in reducing knee pain

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years

  • Chronic knee pain (duration ≥ 6 months) in the index knee

  • Numerical Rating Scale (NRS) pain score ≥ 4/10 for the index knee

  • Failure to achieve adequate pain relief with conservative treatments

  • Positive response to diagnostic genicular nerve block with 0.5% bupivacaine (defined as ≥50% pain reduction lasting at least 3 hours)

  • Ability to understand study procedures and comply with them for the length of the study

Exclusion Criteria:

  • Significant psychiatric or cognitive disorder that may interfere with study participation or outcome assessment

  • Use of other investigational drugs or devices within 30 days prior to study entry

  • Current participation in another clinical trial related to knee pain treatment

  • Current drug or alcohol use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements

  • Inability or unwillingness of individual or legal guardian/representative to provide written informed consent

  • Ongoing litigation related to the knee pain or workers' compensation claims

  • Life expectancy less than 12 months due to any cause

  • Any other condition or circumstance that, in the opinion of the investigator, would make the patient unsuitable for participation in the study or unable to comply with follow-up requirements

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 09/17/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Christine Hunt, D.O.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions